JPRN‐UMIN000004201.
Methods | Study design: RCT |
Participants | 50 |
Interventions |
Remission maintenance therapy group: for 48 weeks with immunomodulator from 2 weeks to 4 weeks following remission induction with tacrolimus No remission maintenance therapy group: with immunomodulator following remission induction with tacrolimus |
Outcomes | Remission rate 48 weeks after the administration of tacrolimus |
Notes | Contact: Kenji Watanabe at kenjiw@med.osaka‐cu.ac.jp |